Matches in Wikidata for { <http://www.wikidata.org/entity/Q93171293> ?p ?o ?g. }
Showing items 1 to 50 of
50
with 100 items per page.
- Q93171293 description "article scientifique publié en 2018" @default.
- Q93171293 description "artículu científicu espublizáu n'avientu de 2018" @default.
- Q93171293 description "scientific article published on 01 December 2018" @default.
- Q93171293 description "wetenschappelijk artikel" @default.
- Q93171293 description "наукова стаття, опублікована в грудні 2018" @default.
- Q93171293 name "Rebuttal Letter to the Editor Kloosterboer et al., Ther Drug Monit 2018;40: 344-350" @default.
- Q93171293 name "Rebuttal Letter to the Editor Kloosterboer et al., Ther Drug Monit 2018;40: 344-350" @default.
- Q93171293 type Item @default.
- Q93171293 label "Rebuttal Letter to the Editor Kloosterboer et al., Ther Drug Monit 2018;40: 344-350" @default.
- Q93171293 label "Rebuttal Letter to the Editor Kloosterboer et al., Ther Drug Monit 2018;40: 344-350" @default.
- Q93171293 prefLabel "Rebuttal Letter to the Editor Kloosterboer et al., Ther Drug Monit 2018;40: 344-350" @default.
- Q93171293 prefLabel "Rebuttal Letter to the Editor Kloosterboer et al., Ther Drug Monit 2018;40: 344-350" @default.
- Q93171293 P1433 Q93171293-54810DB7-1463-47F7-B13D-05B274825423 @default.
- Q93171293 P1476 Q93171293-F59DC906-00FE-4DF6-8F4B-32A07518D5DB @default.
- Q93171293 P2093 Q93171293-348488FF-2E4A-4D20-85C8-B76DF820029F @default.
- Q93171293 P2093 Q93171293-67FB9196-465E-4724-B2DA-DCDF99B6EB7F @default.
- Q93171293 P2093 Q93171293-688E0F23-DD30-48FE-A1E2-332C9CBF3506 @default.
- Q93171293 P2093 Q93171293-8A49E2B5-71B2-499A-B7D5-2E23F346B560 @default.
- Q93171293 P2093 Q93171293-A0D9D3AD-7B6D-4D57-95AB-756E804EF539 @default.
- Q93171293 P2093 Q93171293-B2C3A2F7-BA51-4F10-9811-0D7491039FA1 @default.
- Q93171293 P2093 Q93171293-ECE811FC-40B6-4F29-8A88-F554ABC8A0FC @default.
- Q93171293 P2093 Q93171293-F48AFB17-A3BF-41EF-B7A2-D075ABBB06F6 @default.
- Q93171293 P304 Q93171293-9E1A7573-8D30-4315-8573-4B45C22E64E8 @default.
- Q93171293 P31 Q93171293-8221B537-DD55-4CA8-B5B6-9CC842F14F95 @default.
- Q93171293 P356 Q93171293-BC65DE92-C4DC-4E52-B5EB-F781DCD82A33 @default.
- Q93171293 P433 Q93171293-EFCE4EC0-6D8E-4177-811B-D9F5DE7A577C @default.
- Q93171293 P478 Q93171293-B7BBE30A-C15E-4284-9BB4-C1AC7D1D3C6C @default.
- Q93171293 P50 Q93171293-41861D01-FF50-400E-BCCB-24B6F7A040EF @default.
- Q93171293 P577 Q93171293-71C4E19B-045C-4E05-BA8D-A241653E4979 @default.
- Q93171293 P698 Q93171293-FCB3E359-D9FE-4657-AD87-99552CB14E7D @default.
- Q93171293 P356 FTD.0000000000000560 @default.
- Q93171293 P698 30444494 @default.
- Q93171293 P1433 Q15724567 @default.
- Q93171293 P1476 "Rebuttal Letter to the Editor Kloosterboer et al., Ther Drug Monit 2018;40: 344-350" @default.
- Q93171293 P2093 "Annet Dekker" @default.
- Q93171293 P2093 "Birgit C P Koch" @default.
- Q93171293 P2093 "Bram Dierckx" @default.
- Q93171293 P2093 "Brenda C M de Winter" @default.
- Q93171293 P2093 "Gwen C Dieleman" @default.
- Q93171293 P2093 "Linda Al-Hassany" @default.
- Q93171293 P2093 "Sanne M Kloosterboer" @default.
- Q93171293 P2093 "Soma Bahmany" @default.
- Q93171293 P304 "762" @default.
- Q93171293 P31 Q13442814 @default.
- Q93171293 P356 "10.1097/FTD.0000000000000560" @default.
- Q93171293 P433 "6" @default.
- Q93171293 P478 "40" @default.
- Q93171293 P50 Q87686764 @default.
- Q93171293 P577 "2018-12-01T00:00:00Z" @default.
- Q93171293 P698 "30444494" @default.